control the system concentration limit not concise and does not manage the mutual fund management program as approved. SEC Act S.117 and 125(1) in conjunction with Section 90 of the Penal Code
Public Company Limited (the “Company”) held the Board of Directors’ Meeting No. 6/2017 on December 12, 2017. The meeting unanimously approved significant matters as follows: 1. Approved the reduction of
Directors Meeting No. 6/2018. 2. Approved the company’s performance and Financial Statement in the second quarter of 2018. 3. The meeting unanimously approved the appointment Mr. Yen, Ming-Shan to be Vice
neither been in SEC list of approved issuer nor submitted an application for approval to offer newly issued securities and/or digital token. Therefore, those receiving information or being solicited to
committees and/ or the Company’ s authorized directors to determine the sale price which must not have a discount of not exceeding 10 percent of such fair price and the price must be in the best interest of
follows: 1. Approved the appointment of Mr.Philip Chen Chong Tan as the Bank’s President, as proposed by the Nomination and Remuneration Committee. He will be responsible for the assigned groups in the
(“the Company”) would like to inform that the Board of Directors’ Meeting No.4/2018 on November 14, 2018, approved transactions with connected persons as follow: 1. Financial assistance to KT Medical
exceeding 245 Indian Rupees (two hundred forty-five million Indian Rupees). 2. Approved the assignment of authorized directors or the person assigned by the said directors has the power to negotiate